News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Immdal Ltd Announces Sale of Subsidiary Newport
October 20, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DUBLIN--(BUSINESS WIRE)--Immdal Limited (‘Immdal’), a privately held Irish pharmaceutical healthcare group, today announced the sale of its subsidiary Newport Pharmaceuticals Limited (‘Newport’) to Swiss pharmaceutical company Ewopharma AG.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
Deal-hungry Lilly strikes up to $2.9B immuno play for Merida
August 31, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio
August 28, 2026
·
1 min read
·
Tristan Manalac
Insights
Fragile X at a turning point: Breaking through the clinical bottleneck
August 27, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Deals
Biohaven could get up to $795M in epilepsy alliance with SK Bio
August 26, 2026
·
2 min read
·
Tristan Manalac
